Which institution's scientists developed a promising new malaria vaccine candidate?

ANS:B - Jawaharlal Nehru University

Scientists at the Oxford University’s Jenner Institute have developed a promising new malaria vaccine candidate. This innovative vaccine, known as R21/Matrix-M, represents a significant advancement in the fight against malaria, a disease that continues to affect millions globally. The R21/Matrix-M vaccine has shown promising results in clinical trials, demonstrating a high level of efficacy in protecting against malaria, particularly in high-risk populations such as young children in endemic regions. The development of this vaccine is a major milestone in malaria research, as it aims to provide a more effective and accessible solution to combat the disease. The Jenner Institute, renowned for its expertise in vaccine development, has leveraged its extensive research capabilities to advance this candidate through rigorous testing and trials. The successful development of the R21/Matrix-M vaccine holds the potential to significantly reduce malaria incidence and mortality, offering hope for a major breakthrough in global health and disease prevention.